SUN NGUYEN: Open Payments
NPI 1104245273 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,705 in 115 payments from 20 companies in 2025. Trend: 2023 $1,464 · 2024 $7,624 · 2025 $2,705
Food & beverage: $2,440Education: $265
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $818 |
| Janssen Biotech, Inc. | 12 | $331 |
| UCB, Inc. | 16 | $239 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $200 |
| LEO Pharma Inc. | 9 | $183 |
| GENZYME CORPORATION | 6 | $139 |
| REVANCE THERAPEUTICS, INC. | 2 | $131 |
| Novartis Pharmaceuticals Corporation | 5 | $112 |
| Regeneron Healthcare Solutions, Inc. | 1 | $96 |
| Galderma Laboratories, L.P. | 4 | $91 |
Products named: SKYRIZI, TREMFYA, Bimzelx, DUPIXENT, RINVOQ, BOTOX, DAXXIFY, ADBRY.
Industry payments across PA — which companies pay providers there.
